- $3.50m
- $39.41m
- $64.83m
- 45
- 64
- 15
- 36
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.48 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.05 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -101.75% | ||
Return on Equity | n/a | ||
Operating Margin | -59.48% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 78.01 | 105.62 | 99.5 | 76.35 | 64.83 | 60.74 | 65.32 | -10.1% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Venus Concept Inc. is a global medical technology company. The Company develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and 10 direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.
Directors
- Scott Barry NEC (48)
- Domenic Serafino CEO (60)
- Domenic Penna CFO (59)
- Ross Portaro CEX
- Soren Sinay COO (50)
- Melissa Kang VPR (54)
- Anna Georgiadis VPR (50)
- Yoni Iger VRD (61)
- Keith Sullivan DRC (61)
- Stanley Hollmig IND
- Garheng Kong IND (45)
- Louise Lacchin IND (63)
- Fritz LaPorte IND (51)
- Anthony Natale IND (47)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 22nd, 2002
- Public Since
- October 12th, 2017
- No. of Shareholders
- 71
- No. of Employees
- 292
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
NASDAQ Capital Market
- Shares in Issue
- 1,424,403

- Address
- 235 Yorkland Blvd Suite 900, TORONTO, M2J 4Y8
- Web
- https://www.venusconcept.com/en-uk/
- Phone
- +1 4088836888
- Contact
- Mike Piccinino
- Auditors
- MNP LLP
Upcoming Events for VERO
Q1 2025 Venus Concept Inc Earnings Release
Venus Concept Inc Annual Shareholders Meeting
Venus Concept Inc Annual Shareholders Meeting
Q2 2025 Venus Concept Inc Earnings Release
Similar to VERO
Accelerate Diagnostics
NASDAQ Capital Market
Adagio Medical Holdings
NASDAQ Capital Market
Adapthealth
NASDAQ Capital Market
Aethlon Medical
NASDAQ Capital Market
Agape ATP
NASDAQ Capital Market
FAQ
As of Today at 23:57 UTC, shares in Venus Concept are trading at $2.46. This share price information is delayed by 15 minutes.
Shares in Venus Concept last closed at $2.46 and the price had moved by -67.81% over the past 365 days. In terms of relative price strength the Venus Concept share price has underperformed the S&P500 Index by -70.98% over the past year.
The overall consensus recommendation for Venus Concept is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreVenus Concept does not currently pay a dividend.
Venus Concept does not currently pay a dividend.
Venus Concept does not currently pay a dividend.
To buy shares in Venus Concept you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $2.46, shares in Venus Concept had a market capitalisation of $3.50m.
Here are the trading details for Venus Concept:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: VERO
Based on an overall assessment of its quality, value and momentum Venus Concept is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Venus Concept is $10.60. That is 330.89% above the last closing price of $2.46.
Analysts covering Venus Concept currently have a consensus Earnings Per Share (EPS) forecast of -$33.64 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Venus Concept. Over the past six months, its share price has underperformed the S&P500 Index by -47.75%.
As of the last closing price of $2.46, shares in Venus Concept were trading -46.27% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Venus Concept PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $2.46.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Venus Concept's management team is headed by:
- Scott Barry - NEC
- Domenic Serafino - CEO
- Domenic Penna - CFO
- Ross Portaro - CEX
- Soren Sinay - COO
- Melissa Kang - VPR
- Anna Georgiadis - VPR
- Yoni Iger - VRD
- Keith Sullivan - DRC
- Stanley Hollmig - IND
- Garheng Kong - IND
- Louise Lacchin - IND
- Fritz LaPorte - IND
- Anthony Natale - IND